- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Is Intracranial Atherosclerosis an Independent Risk Factor for Cerebral Atrophy? A Retrospective Evaluation
© Erbay et al; licensee BioMed Central Ltd. 2008
Received: 26 July 2007
Accepted: 22 December 2008
Published: 22 December 2008
Our purpose was to study the association between the intracranial atherosclerosis as measured by cavernous carotid artery calcification (ICAC) observed on head CT and atrophic changes of supra-tentorial brain demonstrated by MRI.
Institutional review board approval was obtained for this retrospective study incorporating 65 consecutive patients presenting acutely who had both head CT and MRI. Arterial calcifications of the intracranial cavernous carotids (ICAC) were assigned a number (1 to 4) in the bone window images from CT scans. These 4 groups were then combined into high (grades 3 and 4) and low calcium (grades 1 and 2) subgroups. Brain MRI was independently evaluated to identify cortical and central atrophy. Demographics and cardiovascular risk factors were evaluated in subjects with high and low ICAC. Relationship between CT demonstrated ICAC and brain atrophy patterns were evaluated both without and with adjustment for cerebral ischemic scores and cardiovascular risk factors.
Forty-six of the 65 (71%) patients had high ICAC on head CT. Subjects with high ICAC were older, and had higher prevalence of hypertension, diabetes, coronary artery disease (CAD), atrial fibrillation and history of previous stroke (CVA) compared to those with low ICAC. Age demonstrated strong correlation with both supratentorial atrophy patterns. There was no correlation between ICAC and cortical atrophy. There was correlation however between central atrophy and ICAC. This persisted even after adjustment for age.
Age is the most important determinant of atrophic cerebral changes. However, high ICAC demonstrated age independent association with central atrophy.
Gradual loss of cerebral tissue in adulthood leads to atrophy in the central nervous system. There may be predilection for atrophy by location such as the infra- vs. supra-tentorial compartments. In the supra-tentorial compartment, cortical or central atrophy types have been recognized [[1, 2] and ]. Although age is the most important determinant of cerebral atrophy , variety of other external or internal factors such as local, systemic or humoral can affect the location, degree and rate of developing atrophy [1, 5]. Considering the aging population across the globe, these risk factors are intense focus of research.
Although the role of cardiovascular risk factors  and even extra-cranial atherosclerosis [[7, 8] and ] on cerebral atrophy has been studied, the impact of intracranial atherosclerosis on atrophy has not been as well evaluated. This has been largely due to difficulty in accurately grading the degree of atherosclerosis. Arterial calcium measured by CT has been recently demonstrated to be a reliable marker for atherosclerosis. Qualitative or quantitative measurement of arterial calcium has been utilized to determine the coronary plaque burden [10–15]. Specifically, the role of intracranial carotid arterial calcium on ischemic cerebral changes has been evaluated in different studies. Cerebral atrophy has not been the focus of attention in these studies however [16, 17].
In this study, we wanted to evaluate the effects of intra-cranial atherosclerosis on supra-tentorial cerebral atrophy patterns. Specifically, we wanted to explore this link by incorporating stroke imaging data . Our first aim was to evaluate possible link between carotid arterial calcium and cerebral atrophy. Second aim of the study was to evaluate whether this link was due to underlying ischemic cerebral changes identifiable by imaging studies or a separate correlation. If proven, this link may expand the scope of chronic atherosclerotic impact in the brain.
We have hypothesized that the presence of intra-cranial atherosclerosis can be an independent risk factor for cerebral atrophy. We have further hypothesized that this risk can be age independent.
Institutional Review Board approved for this retrospective study without requirement for a patient consent. From the stroke database of our institution, we included 68 consecutive patients from January 1, 2001 to December 31, 2003. These patients presented with acute stroke-like symptoms to the emergency room and had  diagnostic quality head CT and brain MRI with diffusion imaging within a week of each other, and  information about cerebrovascular risk factors available on the hospital information system. 3 patients were excluded due to lack of satisfactory imaging. Intracranial mass effects due to large bleeds or infarcts and history of known malignancy or dementia were additional exclusion criteria. There were 65 patients in the final study group including 34 (52%) males and 31 (48%) females with a mean age of 64.6 ± 17.2 years.
A Four-Point Grading Scale for CT ICC.
Absence or near absence of calcifications.
Tiny, scattered calcifications.
Either thick, interrupted calcifications or thin, confluent calcifications.
Thick, contiguous calcifications.
MRI scans were performed on either a 1.5T magnet (Symphony, Siemens Medical Solutions, Erlangen, Germany). All patients went through a standard imaging protocol including; T1-weighted (TR: 550–750 ms; TE: 20–25 ms; 5 mm scan thickness; slice gap: 5 mm; matrix: 256 × 256), T2-weighted (TR: 4,000–5,000 ms; TE: 90–120 ms; 5 mm scan thickness; slice gap: 5 mm; matrix: 256 × 256), Fluid attenuation inversion recovery (FLAIR) (TR: 9000 ms; TE: 100 ms; TI: 2400 ms; 5 mm scan thickness; slice gap: 5 mm; matrix: 192 × 256), and diffusion weighted images. Diffusion images were reconstructed as diffusion maps (b0 1000) and ADC maps.
A neuroradiologist with 12 years of experience analyzed MRI images independently and without the prior knowledge of CT results or risk factor profile.
Cerebrovascular Risk factors
The cerebrovascular risk factors included hypertension, hypercholesterolemia, diabetes, atrial fibrillation, history of coronary artery disease and history of stroke.
Hypertension was defined as diagnosis by a physician, history of treatment with anti-hypertensive medication, systolic blood pressure above 150 mm of Hg and diastolic blood pressure above 95 mm of Hg. Hypercholesterolemia was defined as blood cholesterol level greater than 240 mmol/dl. Diabetes was defined as diagnosis by a physician, history of anti-diabetic medication or fasting blood sugar level greater than140 mmol/dl. Atrial fibrillation was considered present if the patient had a history of it or was being treated for it. Coronary artery disease was considered present if the patient had history of unstable angina, myocardial infarction, coronary angioplasty or coronary artery bypass surgery. History of previous stroke was considered to be present if stroke was diagnosed previously by a physician.
Cerebral Ischemia Scores
Final cerebral ischemic damage is evaluated for periventricular hyperintensity (PVH) and infarcts. PVH is visually graded on FLAIR images (not shown) as outlined in cardiovascular health study [18, 19].
Based on the imaging criteria specified elsewhere ; the cerebral infarcts have been divided into acute versus chronic and small versus large vessel infarcts.
The subjects were stratified into two groups, those with high and low ICAC, respectively. Summary statistics included means ± (standard deviations) for continuous risk factors such as age, and counts and proportions for the remaining discrete risk factors such as sex, hypertension, diabetes mellitus, cholesterol, coronary artery disease, history of stroke and atrial fibrillation.
The primary statistical hypothesis test postulated that the atherosclerosis can be a risk factor for cerebral atrophy. The above cerebrovascular risk factors between the subjects with high and low ICAC were correlated using a univariate Chi-square test. The mean age was compared by a two-sample t-test between these two ICAC groups.
The secondary hypothesis postulated that these factors can also be age independent. Multivariate stepwise logistic regression analysis was performed to determine the association of each atrophy subtype with all risk factors and cerebral ischemia scores combined.
For all hypothesis tests, a statistical significance was reached when the p-value p = 0.05 as the cutoff threshold. Statistical software used was SPSS.
Summary Statistics of Characteristics and Cerebrovascular Risk Factors
All Subjects (n = 65)
Subjects with High Calcium (n = 46)
Subjects with Low Calcium (n = 19)
Age (mean +- SD)
64.6 +/- 17.2
71.7 +/- 11.1
Sex (male) (%)
Diabetes Mellitus (%)
Coronary Artery Disease (%)
History of Stroke (%)
Atrial Fibrillation (%)
Summary of Cortical and Ventricular Atrophy in Subjects with and without ICAC
Type of Calcification
All Subjects (n = 65)
Subjects with High Calcium (n = 46)
Subjects with Low Calcium (n = 19)
3.7 +/- 1.8
4.2 +/- 1.7
2.55 +/- 1.6
Central (ventricular) Atrophy
4.71 +/- 2.26
5.56 +/- 1.78
2.65 +/- 1.97
Correlation of MRI Demonstrated Brain Infarct Subtypes with ICAC
Total Subjects n = 65
Subjects with High Calcium n = 46
Subjects with Low Calcium n = 19
P-value after an (adjustment for age, other risk factors) **
Multivariate Logistic Regression Analysis for Cortical Atrophy
Multivariate Logistic Regression Analysis for Central Atrophy
In conclusion, our study is unique to evaluate the role of arterial calcium from CT as a measure of atherosclerosis on cerebral atrophy patterns. We have found age independent correlation between central atrophy and intracranial atherosclerosis. This distinct link has to be further substantiated in large, longitudinal studies. We have not found any correlation between intracranial atherosclerosis and cortical atrophy.
Age is the most dominant determinant of cerebral atrophic changes . Recognizing the factors that accelerate rates of cerebral atrophic and degenerative changes is important because they may predispose to cognitive declines. More importantly, the treatment or controlling these noxious factors may reverse the course of the process as reported in abstaining from alcohol .
There is an agreement in the literature for existence of cortical and central atrophy subtypes in the supratentorial brain. Different quantitative analysis indices have been developed and utilized for these atrophy patterns [[1, 2] and ]. Our results support the existence of differential cerebral atrophy types since we have found correlation only between intracranial atherosclerosis and central atrophy. There is likely an intricate and rather complex relationship between these two subtypes of atrophy. For example in age related global atrophy, there is more pronounced central atrophy than cortical atrophy . Additionally certain risk factors, such as alcohol or chronic hemodialysis, may promote both types of these atrophy patterns [1, 5]. Interestingly in patients with dementia, correlation has been reported with cortical  or central atrophy  in different studies.
Cortical atrophy may have a pre-requisite of direct neuronal loss as a result of noxious injury. Among the many offending mechanisms, the most common source of this type of atrophy, after old age, is probably Alzheimer's disease. Selective temporal and parietal cortical atrophy in Alzheimer's is associated with diffuse neuronal depletion in the involved cortical samples of these patients. Although the cortical atrophy can be seen rarely as a static phenomenon in the setting of mental retardation or in patients with certain psychiatric conditions , in elderly population, it can assume more dynamic component in hippocampus with measurable annual volume loss. These rates have been reported to be approximately 2.5 times greater in patients with AD than in individually age- and gender-matched control subjects .
On the other hand, the central atrophy may reflect more widespread changes in the parenchyma. Pathologic processes causing extensive demyelination without or with neuronal damage may induce this pattern. It has been claimed that central atrophy can be the measure of a total tissue loss rather than index of focal demyelinating lesions in MS . Ischemic demyelination is the most common form of chronic vasculopathy, typically related to underlying hypertension. Therefore, it is not surprising that in our study, we have found correlation between intracranial atherosclerosis and central atrophy and with acute small vessel infarcts but not with PVH. PVH has not been associated with either atrophy type in our multivariate analysis. Our results therefore may suggest a more selective role of intracranial atherosclerosis on central atrophy even in the absence of advanced leuko-araiosis. With old age, leuko-araiosis may increase in a linear fashion in both sexes  and cerebral perfusion decreases [4, 24]. In different studies, progressive leuko-araiosis have correlated with cortical perfusion declines  and central atrophy [4, 20]. Our results are in favor of earlier studies reporting association between central atrophy and vascular dementia but not with pre-senile dementia .
The impact of degenerative cerebral changes evidenced by neuroimaging studies on cognitive decline has not been well understood. However incidence of diffuse cerebral ischemic changes increases in the cognitively impaired groups; 12% in patients with no evidence of dementia, 32% in those with isolated memory loss, and 59% in patients with possible or probable dementia. Thromboembolic rather than hemodynamic basis has been suggested for pathogenesis of diffuse ischemia [3, 26]. The limitations exist for evaluating the role of atrophy indices on cognition due to significant overlap being present between measurable indices of cognitively intact and declined populations. By reflecting more diffuse changes in the cerebral parenchyma, central atrophy is more likely to be associated with cognitive dysfunction [25, 26]. Although associated with all types of atrophy, HIV and alcohol are more likely to demonstrate central atrophy in patients with cognitive dysfunction [[5, 27, 28] and ]. Similar observations have been made in the dementia patients for whom central atrophy can predict cognitive decline. In contrast, for their age matched non-demented controls, the cortical atrophy is related to lower scores on a cognitive test . Our study lacks the data pertaining to the cognitive status of our patients although there were no patients with dementia. Future studies are needed in this regard. We have observed similar results between intracranial carotid arterial calcifications and central atrophy in a small prospective study .
Cardiovascular risk factors such TIAs, hypertension, smoking, hyperlipidemia, excessive alcohol consumption and male gender may independently accelerate cerebral atrophy and decrease cortico-subcortical perfusion perfusions . Additional correlations have been reported between diffuse cerebral ischemic changes and systolic blood pressure, heart disease, peripheral vascular disease, diabetes, focal neurological signs on examination and central atrophy on CT [6, 27]. Based on our results, intracranial atherosclerosis may emerge as a separate, age independent risk factor for central atrophy. Correlation is also independent of underlying cerebral ischemic changes as identified by routine imaging studies. Interventions targeting to control or to modify some of these cardiovascular risk factors and now, atherosclerosis should be employed for those with accelerated cerebral atrophic and degenerative changes identified by neuroimaging studies. Accurate diagnosis of central atrophy can be hindered by its mimickers on imaging studies however. This is especially valid for communicating or normal pressure hydrocephalus. Like central atrophy, these can also cause ventricular dilatation. Subtle clues described for communicating hydrocephalus have to be identified by careful analysis of sagittal midline T1-weighted images as distal dilatation (funneling) of the aqueduct towards the fourth ventricle (detected in 33.3% of these patients) and elevation of corpus callosum .
- Kamata T, Hishida A, Takita T, Sawada K, Ikegaya N, Maruyama Y, Miyajima H, Kaneko E: Morphologic abnormalities in the brain of chronically hemodialyzed patients without cerebrovascular disease. Am J Nephrol. 2000, 20 (1): 27-31. 10.1159/000013551.View ArticlePubMedGoogle Scholar
- Brinkman SD, Sarwar M, Levin HS, Morris HH: Quantitative indexes of computed tomography in dementia and normal aging. Radiology. 1981, 138 (1): 89-92.View ArticlePubMedGoogle Scholar
- Jacoby RJ, Levy R: Computed tomography in the elderly. 2. Senile dementia: diagnosis and functional impairment. Br J Psychiatry. 1980, 136: 256-69. 10.1192/bjp.136.3.256.View ArticlePubMedGoogle Scholar
- Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R: White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke. 1995, 26 (7): 1171-7.View ArticlePubMedGoogle Scholar
- Muronen A, Bergman H, Hindmarsh T, Telakivi T: Influence of improved drinking habits on brain atrophy and cognitive performance in alcoholic patients: a 5-year follow-up study. Alcohol Clin Exp Res. 1989, 13 (1): 137-41. 10.1111/j.1530-0277.1989.tb00298.x.View ArticleGoogle Scholar
- Knopman DS, Mosley T, Catellier DJ, Sharrett AR: Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology. 2005, 65 (6): 876-881. 10.1212/01.wnl.0000176074.09733.a8.View ArticlePubMedGoogle Scholar
- Kin T, Yamano S, Sakurai R, Kajitani M, Okahashi Y, Nishiura N, Saito Y, Ueno S: Carotid atherosclerosis is associated with brain atrophy in Japanese elders. Gerontology. 2007, 53 (1): 1-6. 10.1159/000095385.View ArticlePubMedGoogle Scholar
- Manolia TA, Burke GL, O'leary DH, Evans G, Beauchamp N, Knepper L, Ward B: Relationship of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: The cardiovascular Health Study. CHS Collaborative Research Group. Artherioscl Thromb Vasc Biol. 1999, 19 (2): 356-65.View ArticleGoogle Scholar
- Scuteri A, Brancati AM, Gianni W, Assisi A, Volpe M: Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. J Hypertens. 2005, 23 (6): 1211-6. 10.1097/01.hjh.0000170384.38708.b7.View ArticlePubMedGoogle Scholar
- Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS: Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995, 92: 2157-2162.View ArticlePubMedGoogle Scholar
- Arad Y, Spadaro LA, Goodman K, Lledo-Perez A, Sherman S, Lerner G, Guerci AD: Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects. Circulation. 1996, 93: 1951-1953.View ArticlePubMedGoogle Scholar
- Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD: Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000, 36: 1253-1260. 10.1016/S0735-1097(00)00872-X.View ArticlePubMedGoogle Scholar
- Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM: Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol. 2000, 86: 495-498. 10.1016/S0002-9149(00)01000-6.View ArticlePubMedGoogle Scholar
- Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000, 101: 850-855.View ArticlePubMedGoogle Scholar
- Simon A, Giral P, Levenson J: Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men: association with coronary risk profile. Circulation. 1995, 92: 1414-1421.View ArticlePubMedGoogle Scholar
- Erbay S, Han R, Baccei S, Krakov W, Zou K, Bhadelia R, Polak J: Intracranial Carotid Artery Calcification on Head CT, and Its Association with Ischemic Changes on Brain MRI, in Patients Presenting with Stroke-like Symptoms. Retrospective Analysis Neuroradiology. 2007, 49: 27-33.View ArticlePubMedGoogle Scholar
- Babiarz LS, Yousem DM, Bilker W, Wasserman BA: Middle cerebral artery infarction: Relationship of cavernous carotid artery calcification. Am J Neuroradiol. 2005, 26: 1505-11.PubMedGoogle Scholar
- Yue NC, Arnold AM, Longstreth WT, Elster AD, Jungreis CA, O'Leary DH, Poirier VC: Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology. 1997, 202 (1): 33-9.View ArticlePubMedGoogle Scholar
- Bryan RN, Wells SW, Miller TJ, Elster AD, Jungreis CA, Poirier VC, Lind BK, Manolio TA: Infarct like lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly – data from the Cardiovascular Health Study. Radiology. 1997, 202 (1): 47-54.View ArticlePubMedGoogle Scholar
- Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O: Age dependent white matter lesions and brain volumechanges in healthy volunteers. Acta Radiol. 1994, 35 (2): 117-22.View ArticlePubMedGoogle Scholar
- Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Kokmen E: Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998, 51 (4): 993-9.View ArticlePubMedPubMed CentralGoogle Scholar
- Vita A, Sacchetti E, Valvassori G, Cazzullo CL: Brain morphology in schizophrenia: a 2- to 5-year CT scan follow-up study. Acta Psychiatr Scand. 1988, 78 (5): 618-21. 10.1111/j.1600-0447.1988.tb06394.x.View ArticlePubMedGoogle Scholar
- Kalkers NF, Vrenken H, Uitdehaag BM, Polman CH, Barkhof F: Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue. Mult Scler. 2002, 8 (5): 410-4. 10.1191/1352458502ms833oa.View ArticlePubMedGoogle Scholar
- Akiyama H, Meyer JS, Mortel KF, Terayama Y, Thornby JI, Konno S: Normal human aging: factors contributing to cerebral atrophy. J Neurol Sci. 1997, 152 (1): 39-49. 10.1016/S0022-510X(97)00141-X.View ArticlePubMedGoogle Scholar
- Wallin A, Blennow K, Uhlemann C, Langstrom G, Gottfries CG: White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia–diagnostic and pathogenetic aspects. Acta Neurol Scand. 1989, 80 (6): 518-23.View ArticlePubMedGoogle Scholar
- Amar K, Lewis T, Wilcock G, Scott M, Bucks R: The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study. Age Ageing. 1995, 24 (5): 411-5. 10.1093/ageing/24.5.411.View ArticlePubMedGoogle Scholar
- Luoto R, Manolio T, Meilahn E, Bhadelia R, Furberg C, Cooper L, Kraut M: Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J Am Geriatr. 2000, 48 (5): 467-472. (SeeComment in: J Am Geriatr Soc. 2000 May;48(5):588-9)View ArticleGoogle Scholar
- Jakobsen J, Gyldensted C, Brun B, Bruhn P, Helweg-Larsen S, Arlien-Soborg P: Cerebral ventricular enlargement relates to neuropsychological measures in unselected AIDS patients. Acta Neurol Scand. 1989, 79 (1): 59-62.View ArticlePubMedGoogle Scholar
- Elovaara I, Poutiainen E, Raininko R, Valanne L, Virta A, Valle SL, Lahdevirta J, Iivanainen M: Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response. J Neurol Sci. 1990, 99 (2–3): 121-36. 10.1016/0022-510X(90)90149-H.View ArticlePubMedGoogle Scholar
- Erbay S, Shah , O'Callaghan M, Paraq Shah MD, Jonathan Kini MD, Jennifer , Bassett Midle P, Polak J: Prospective Evaluation ofthe Role of Atherosclerosis on Cerebral Atrophy. J Neuroimaging. 2007, 18 (4): 375-380. (Web pages of online article).View ArticleGoogle Scholar
- Kurihara Y, Simonson TM, Nguyen HD, Fisher DJ, Lin CS, Sato Y, Yuh WT: MR imaging of ventriculomegaly–a qualitative and quantitative comparison of communicating hydrocephalus, central atrophy, and normal studies. J Magn Reson Imaging. 1995, 5 (4): 451-6. 10.1002/jmri.1880050415.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/8/51/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.